These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3965239)

  • 1. Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration.
    Smith RA; Norris F; Palmer D; Bernhardt L; Wills RJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):85-8. PubMed ID: 3965239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of recombinant alpha A interferon following I.V. infusion and bolus, I.M., and P.O. administrations to African green monkeys.
    Wills RJ; Spiegel HE; Soike KF
    J Interferon Res; 1984; 4(3):399-409. PubMed ID: 6491397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection.
    Wills RJ; Dennis S; Spiegel HE; Gibson DM; Nadler PI
    Clin Pharmacol Ther; 1984 May; 35(5):722-7. PubMed ID: 6713784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog.
    Gibson DM; Cotler S; Spiegel HE; Colburn WA
    J Interferon Res; 1985; 5(3):403-8. PubMed ID: 4056487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application.
    Supersaxo A; Hein W; Gallati H; Steffen H
    Pharm Res; 1988 Aug; 5(8):472-6. PubMed ID: 3244653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.
    Ferraiolo BL; Fuller GB; Burnett B; Chan E
    J Biol Response Mod; 1988 Apr; 7(2):115-22. PubMed ID: 3129541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of 5-fluorouracil and recombinant alpha 2a-interferon in patients with advanced colorectal carcinoma.
    Wadler S; Goldman M; Lyver A; Wiernik PH
    Cancer Res; 1990 Apr; 50(7):2056-9. PubMed ID: 2317795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous and intramuscular pharmacokinetics of recombinant leukocyte A interferon.
    Bornemann LD; Spiegel HE; Dziewanowska ZE; Krown SE; Colburn WA
    Eur J Clin Pharmacol; 1985; 28(4):469-71. PubMed ID: 4029251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
    Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
    J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer.
    Danhauser LL; Freimann JH; Gilchrist TL; Gutterman JU; Hunter CY; Yeomans AC; Markowitz AB
    J Clin Oncol; 1993 Apr; 11(4):751-61. PubMed ID: 8478667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
    Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
    J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
    Hashizume S
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):284-8. PubMed ID: 3970552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
    Quesada JR; Evans L; Saks SR; Gutterman JU
    J Biol Response Mod; 1988 Jun; 7(3):234-9. PubMed ID: 3134511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular delivery.
    Collins JM; Riccardi R; Trown P; O'Neill D; Poplack DG
    Cancer Drug Deliv; 1985; 2(4):247-53. PubMed ID: 4063949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD
    Cancer Res; 1985 Sep; 45(9):4447-53. PubMed ID: 4028027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL; McAtee N; Murphy RF; Balis FM; Steinberg SM; Hamilton JM; Sorensen JM; Sartor O; Kramer BS; Goldstein LJ
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
    Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM
    J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
    Yoshida R; Murray HW; Nathan CF
    J Exp Med; 1988 Mar; 167(3):1171-85. PubMed ID: 2965208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.